466 F.3d 187 (2nd Cir. 2005), 03-7641, In re Tamoxifen Citrate Antitrust Litigation
Linked as:
Extract
466 F.3d 187 (2nd Cir. 2005), 03-7641, In re Tamoxifen Citrate Antitrust Litigation
No longer available (Autolink)
See the full content of this document
This document cites
- US Code - 35 U.S.C. § 154 Contents and Term of Patent; Provisional Rights
- US Code - 35 U.S.C. § 282 Presumption of Validity; Defenses
- Code of Federal Regulations - Approval of an NDA and an ANDA
- Code of Federal Regulations - Date of approval of a 505(b)(2) application or ANDA
- US Code - 28 U.S.C. § 1295 Jurisdiction of the United States Court of Appeals For the Federal Circuit